Source: BioPortfolio

Inotek Pharmaceuticals: Inotek Pharmaceuticals Corp RCKT Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250

SummaryInotek Pharmaceuticals Corp IPC is a clinicalstage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company's trabodenoson is a selective a...

Read full article »
Annual Revenue
$100K-5.0M
Employees
250-500
David P. Southwell's photo - President & CEO of Inotek Pharmaceuticals

President & CEO

David P. Southwell

CEO Approval Rating

70/100

Read more